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Abstract
Introduction:  Hypercalcemia is well described in various granulomatous disorders, such as
sarcoidosis, tuberculosis, berylliosis, leprosy and fungal infections. However, the association of
Paracoccidioides brasiliensis and hypercalcemia is rare: to the best of our knowledge, only two cases
have previously been reported, and neither had a clear documentation of the etiology of the
hypercalcemia.
Case presentation: We report the case of a 22-year-old man in whom disseminated infection
with paracoccidioidomycosis was associated with hypercalcemia. The patient had a high normal
serum level of 1,25-dihydroxyvitamin D and a suppressed parathyroid hormone value, an indication
that the hypercalcemia was not mediated by parathyroid hormone and might be associated with
1,25-dihydroxyvitamin D.
Conclusion: The episode resolved readily with administration of corticosteroids, an outcome
suggesting that this is an effective treatment of hypercalcemia of this origin. On follow-up, while
receiving antifungal therapy for P. brasiliensis the patient's calcium values remained normal.
Introduction
Hypercalcemia is well described in various granuloma-
tous disorders, such as sarcoidosis, tuberculosis, beryllio-
sis, leprosy and fungal infections. Among the fungal
diseases, disseminated candidiasis, histoplasmosis, cryp-
tococcosis and coccidioidomycosis have rarely been
implicated as causes of hypercalcemia [1-5]. In this report
we describe a patient in whom hypercalcemia was associ-
ated with disseminated infection with Paracoccidioides bra-
siliensis  and a high normal serum level of 1,25-
dihydroxyvitamin D.
Case presentation
The patient, a 22-year-old male agriculturalist was admit-
ted to our hospital in November 2006 with asthenia,
weight loss, fever, diffuse enlargement of cervical lymph
nodes and enlarged liver and spleen. The patient's temper-
ature was 38.5°C and his blood pressure was 120/80
mmHg with a pulse of 96 beats per minute.
Initial laboratory studies included an erythrocyte sedi-
mentation rate of 89 mm/hour, serum hemoglobin of
11.4 g/dl, white blood cell count of 13,690/mm3 (27%
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eosinophils), serum albumin of 2.4 g/dl, normal serum
urea, creatinine, sodium and potassium. On admission,
the patient had a total serum calcium level of 10.4 mg/dl
(normal range 8.4 to 9.7 mg/dl; ~12 mg/dl when cor-
rected for albumin), ionized calcium of 1.46 mmol/l
(normal range 1.15 to 1.29 mmol/l) and phosphorus of
4.9 mg/dl (normal range 2.7 to 4.5 mg/dl). An aspiration
of the cervical lymph node demonstrated P. brasiliensis.
Results of other laboratory tests performed to help assess
the cause of the hypercalcemia were as follows: thyroid
stimulating hormone 4.51 IU/ml (normal range 0.41 to
4.5 IU/ml); parathyroid hormone (PTH) 3.4 pg/ml (nor-
mal range 15 to 65 pg/ml); 1,25-dihydroxyvitamin D 49.4
pg/ml (normal range 15.9 to 55.6 pg/ml); and 24-hour
urinary calcium 856.55 mg (normal range 100 to 300 mg/
24 hours). Chest X-ray and bone scans were normal. A
computed tomography scan of the chest and abdomen
revealed no underlying malignancy. Other causes of
hypercalcemia such as vitamin A and D intoxication, sar-
coidosis, multiple myeloma, milk-alkali syndrome, adre-
nal insufficiency and immobilization were excluded on
the basis of laboratory and clinical data.
Despite the administration of hydration with normal
saline and furosemide therapy, the patient's calcium level
increased to 1.59 mmol/l. Specific treatment for paracoc-
cidioidomycosis was initiated with trimethoprim-sulfam-
ethoxazole. At that time, prednisone (20 mg/day) was
added to the regimen. On the 13th day of hospitalization,
the ionized calcium level had decreased to 1.34 mmol/l
and on the day of discharge from hospital this level was
1.26 mmol/l. The patient received follow-up examina-
tions until May 2007 and during this time has been
asymptomatic, with normal levels of serum calcium and
1,25-dihydroxyvitamin D (22.4 pg/ml).
Discussion
We have reported the case of a patient presenting with
hypercalcemia complicating disseminated infection with
paracoccidioidomycosis. Hypercalcemia is well described
in various granulomatous disorders; however, the associ-
ation of P. brasiliensis and hypercalcemia is rare. To the
best of the authors' knowledge, only two cases have been
reported previously, neither of which offered a clear doc-
umentation of the etiology of the hypercalcemia [6,7].
The endogenous overproduction of 1,25-dihydroxyvita-
min D by activated macrophages seems to have a central
causative role in some granuloma-forming diseases, par-
ticularly sarcoidosis [8], although it is not uniformly
observed [5,8]. In our patient, the high normal levels of
1,25-dihydroxyvitamin D suggest that it may have had a
role in the hypercalcemia.
Our patient demonstrated total and ionized hypercal-
cemia, associated with low serum PTH, elevated serum
phosphorous and normal renal function. The elevation of
1,25-dihydroxyvitamin D (high normal limit) was unu-
sual for the suppressed PTH and elevated phosphorous
levels, suggesting an inappropriately elevated production
or decreased clearance of 1,25-dihydroxyvitamin D [9].
The hypercalcemia was initially treated with hydration
and furosemide, without improvement. Hypercalcemia
normalized when prednisone 20 mg was initiated.
Although antifungal therapy may have contributed to a
partial improvement of the hypercalcemia, a more likely
explanation is that the prompt response was due to treat-
ment with prednisone. Thus, 1,25-dihydroxyvitamin D
might have a role in the pathogenic mechanism of hyper-
calcemia in paracoccidioidomycosis.
Conclusion
We have described a patient in whom hypercalcemia was
associated with disseminated infection with P. brasiliensis
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